MICROTECH MED-B(02235): CSRC Issues Filing Notice Regarding the Company's Implementation of Full Circulation of H Shares
MicroTech Medical-B (02235) announced that the Company has recently received a filing notice issued by the China Securities Regulatory Commission regarding the full circulation of 250 million domestic shares of the Company. According to the filing notice, the Company has completed the filing with the CSRC for the conversion of the aforementioned domestic shares into H shares of the Company and their listing on the Stock Exchange.
MICROTECH MED-B (02235) announced that the Company has recently received a filing notice issued by the China Securities Regulatory Commission regarding the full circulation of 250 million Domestic Shares of the Company. According to the filing notice, the Company has completed the filing with the CSRC for the conversion of the aforementioned Domestic Shares into H Shares of the Company and their listing on the Stock Exchange.
Related Articles
MEGA GENOMICS (06667) repurchased 90,000 shares for HK$638,300 on October 20.
TIANYU SEMI (02658) repurchased 34,000 shares on October 20 for HK$1,499,900.
B&K CORP-B (02396): Jia Lijia Appointed as Chief Executive Officer of the Company
MEGA GENOMICS (06667) repurchased 90,000 shares for HK$638,300 on October 20.
TIANYU SEMI (02658) repurchased 34,000 shares on October 20 for HK$1,499,900.
B&K CORP-B (02396): Jia Lijia Appointed as Chief Executive Officer of the Company
